Public announcement of Open Offer for acquisition of Company Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.2 pts more than Nifty Microcap 250 and 5.4 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aspira Pathlab & Diagnostics has informed BSE about an Open Offer made by a group of 5 acquirers — Mr. Arvind Karsandas Bhanushali, Mrs. Deepali Arvind Bhanushali, Mr. Jay Arvind Bhanushali, Mr. Nikunj Velji Mange, and Mr. Raj Arvind Bhanushali — along with a person acting in concert (Mrs. Shraddha Nikunj Mange). The offer is to acquire up to 26,76,180 equity shares, representing 26% of the company's voting share capital, from public shareholders. The offer price is Rs. 55 per share, payable in cash, taking the total maximum consideration to about Rs. 14.72 crore. The offer is being made under SEBI's Takeover Regulations to consolidate the promoter group's holding, and after full acceptance, the acquirers' combined stake will rise to around 49.82%. The acquirers have stated they do not intend to delist the company, and the offer is not conditional on any minimum acceptance level.
Existing public shareholders can tender their shares at Rs. 55 per share in cash until the offer window closes. The open offer signals consolidation of promoter family control in Aspira Pathlab, with no threat of delisting, so the stock may trade closer to the offer price in the near term.